Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Decreases By 29.4%

BIO-key International Inc. (NASDAQ:BKYI) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 158,340 shares, a decline of 29.4% from the February 26th total of 224,434 shares. Currently, 1.5% of the company’s shares are sold short. Based on an average daily trading volume, of 583,713 shares, the short-interest ratio is presently 0.3 days.

BIO-key International Price Performance

Shares of BKYI opened at $0.57 on Monday. The stock has a market cap of $6.22 million, a P/E ratio of -0.55 and a beta of 0.41. BIO-key International has a 1 year low of $0.51 and a 1 year high of $1.97. The stock’s 50-day moving average price is $0.63 and its two-hundred day moving average price is $0.70. The company has a current ratio of 1.26, a quick ratio of 1.13 and a debt-to-equity ratio of 0.17.

Institutional Investors Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC grew its position in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent reporting period. Institutional investors own 26.51% of the company’s stock.

Analyst Ratings Changes

BKYI has been the topic of several analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, January 21st. Wall Street Zen upgraded shares of BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.